Yokohama, Japan

Mitsuio Onofusa

This inventor holds 1 USPTO granted patent. Top assignee: Mitsui Toatsu Chemicals, Incorporated. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitsuio Onofusa. Retrieved from https://idiyas.com/inventor/mitsuio-onofusa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mitsuio Onofusa: Innovator in Genetic Research

Introduction

Mitsuio Onofusa is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of genetic research, particularly through his innovative patent.

Latest Patents

Onofusa holds a patent for a "Method and apparatus for cleaving deoxyribonucleic acid." This invention showcases his expertise in molecular biology and its applications in various scientific fields. He has 1 patent to his name.

Career Highlights

Mitsuio Onofusa is currently employed at Mitsui Toatsu Chemicals, Incorporated, where he continues to work on advancements in chemical and biological research. His role at the company allows him to collaborate with other experts in the field.

Collaborations

Some of his notable coworkers include Tamotsu Minami and Nobumi Kusuhara. Their collective efforts contribute to the innovative environment at Mitsui Toatsu Chemicals.

Conclusion

Mitsuio Onofusa is a distinguished inventor whose work in genetic research has the potential to impact various scientific disciplines. His contributions reflect the importance of innovation in advancing our understanding of molecular biology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…